Aurinia Pharmaceuticals Inc. buy BiotechBee
Start price
04.01.23
/
60%
€6.46
Target price
31.12.25
€12.00
Performance (%)
63.49%
End price
05.05.23
€10.56
Summary
This prediction ended on 05.05.23 with a price of €10.56. With a performance of 63.49% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | -0.854% | -0.854% | 44.316% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
According to BiotechBee what are the pros and cons of Aurinia Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year